STAT+: Pharmalittle: We’re reading about FDA’s Pazdur retiring, Europe’s reaction to U.S.-U.K. pharma deal, and more

Richard Pazdur, the FDA's top drug regulator, has filed papers to retire at the end of this month, adding to the turmoil at the agency